Rezolute Announces Positive Data from its Phase 2b (RIZE) Study of RZ358 in Patients with Congenital Hyperinsulinism May 1, 2022 by Admin Resolute Announces Positive Data From Its Phase 2B (RIZE) Study Of RZ358 In Patients With Congenital Hyperinsulinism – TechiLive.in House health Rezolute announces positive data from its Phase 2b (RIZE) study, the study of RZ358 in patients with congenital hyperinsulinism Source link
